|
Li-Fraumeni Syndrome in Brazil
|
ZIA CP010144-10769
|
$12,981
|
Achatz, Maria Isabel
|
DCEG (NCI)
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-04
|
$400,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-03S1
|
$154,939
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-04
|
$737,200
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-04
|
$435,560
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-04
|
$637,150
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
1R01CA210911-01A1
|
$348,844
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
1U24CA220245-01
|
$592,709
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Development of a New Generation Micro-CT imaging for Functional and Molecular Imaging of Cancer
|
5R01CA196667-03
|
$476,231
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$218,891
|
Barr, Frederic
|
CCR (NCI)
|
|
Studies of gene fusions in rhabdomyosarcoma
|
ZIA BC 011387
|
$547,229
|
Barr, Frederic
|
CCR (NCI)
|
|
Epigenetic studies in rhabdomyosarcoma
|
ZIA BC 011423
|
$328,337
|
Barr, Frederic
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-04
|
$1,316,888
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
5P50CA127003-10
|
$2,293,187
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
|
1F31CA213965-01A1
|
$44,044
|
BAYLES, IAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA042014-28S1
|
$249,799
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S2
|
$123,315
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S3
|
$46,117
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S4
|
$59,999
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S5
|
$113,563
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S6
|
$75,709
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S7
|
$75,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S8
|
$166,146
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-28
|
$2,284,983
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma
|
5R00CA178207-05
|
$236,243
|
BENAVENTE, CLAUDIA
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$312,747
|
Beutler, John
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,201,344
|
Bilusic, Marijo
|
CCR (NCI)
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-03
|
$2,373,000
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Minimally invasive image-guided tumor ablation in an oncogenic pig model
|
5R21CA195433-02
|
$266,380
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$245,217
|
Burke, Terrence
|
CCR (NCI)
|
|
Effects of Photodynamic Therapy on Tumor Oxygenation and Blood Flow
|
5R01CA085831-14
|
$324,000
|
BUSCH, THERESA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$24,641
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway
|
ZIA BC 011131
|
$513,634
|
Byrd, R. Andrew
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA016058-41S1
|
$139,874
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-41S2
|
$125,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-41S3
|
$200,000
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-41
|
$5,040,816
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
|
1U01CA224166-01
|
$1,639,796
|
CANTER, ROBERT
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|